Incorporation of additional QC during subject sample analysis. [Bioanalytics]

posted by shreyas goswami  – India, 2024-03-12 10:22 (813 d 16:02 ago) – Posting: # 23902
Views: 6,512

Dear Members,

Seeking for better clarity ;-)

As stated in RDC27/2012 (ANVISA) "at least two QCs are within the range of measured concentrations." unlike other regulatory agencies where it is stated " At least two QCs should be below AVG Cmax".

How it should be evaluated during subject sample analysis for ANVISA submission studies?

Can we set pre defined criteria like....67% of total periods meet above mentioned criteria or it should be on the basis of average Cmax? :confused:

Kindly share your practice and inputs.

Regards,
Shreyas Goswami.

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
415 visitors (0 registered, 415 guests [including 21 identified bots]).
Forum time: 03:24 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5